Study Details

General Information

Sanofi LPS14347

A Randomized, open-label, parallel group real work pragmatic trial to assess the clinical and health outcomes of Toujeo compared to commercially available basal insulins for initiation of therapy in insulin naïve patients with uncontrolled type 2 diabetes mellitus.

ProtocolLPS14347
Identifier
UID38504baf-6237-4598-baf6-fd54be6953e1
StatusNot Selected
Phase
Category
Launch Year2015
NCT Number-
Created2015-04-01 11:24
Last Updated2015-04-01 11:24

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout DateNo
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMartinez, GilbertGJMartinezNo
Recruiter-No
CoordinatorRocha, LuisLRochaNo
Regulatory-No

Custom Fields

No custom fields.

Sponsor & Organization

SponsorSanofi-Aventis
DivisionSanofi-Aventis
TeamSanofi-Aventis
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CRO
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorLightgray
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?